Comparison of methods used to measure serum iron in the presence of iron gluconate or iron dextran

Clinical Chemistry

Volumn 45, Issue 6 I, 1999, Pages 898-901

  Seligman, Paul A ^a   Schleicher, Rhoda B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; ERYTHROPOIETIN; FERROUS GLUCONATE; GUANIDINE; HYDROXYLAMINE; IRON DEXTRAN; IRON LECITHIN COMPLEX; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; IRON BLOOD LEVEL; IRON OVERLOAD; MEASUREMENT; SERUM;

EID: 0033036913     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.6.898     Document Type: Article

References (12)

1. Crosby WH. Prescribing iron? Think safety. Arch Intern Med 1978;138: 766-7.
2. Robotham JL, Lietman PS. Acute iron poisoning. A review. Am J Dis Child 1980;134:875-9.
3. Zanen AL, Adriaansen HJ, van Bommel EFH, Posthuma R, de Jong GMT. 'Oversaturation' of transferrin after intravenous ferric gluconate (Ferrlecit®) in hemodialysis patients. Nephrol Dial Transplant 1996;11:820-4.
4. National Kidney Foundation-Dialysis Outcomes Quality Initiative. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997;30(Suppl 3):S192-240.
5. Jacobs JC, Alexander NM. Colorimetry and constant-potential coulometry determinations of transferrin-bound iron, total iron-binding capacity, and total iron in serum containing iron-dextran, with use of sodium dithionite and alumina columns. Clin Chem 1990;36:1803-7.
6. Hillman RS. Hematopoietic agents: growth factors, minerals, and vitamins. In: Hardman JG, Gilman AG, Limbird LE, eds. Goodman & Gilman's the pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996:1311-40.
7. Henderson PA, Hillman RS. Characteristics of iron dextran utilization in man. Blood 1969;34:357-75.
8. American Regent Laboratories. Dexferrum, iron dextran injection, USP. Package insert. Shirley, NY: American Regent Laboratories, 1996.
9. Nissenson AR, Lindsay RM, Swan S, Seligman PA, Strobos J. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American trial. Am J Kidney Dis 1999;33:471-82.
10. Persijn JP, Van Der Slik W, Riethorst A. Determination of serum iron and latent iron-binding capacity (LIBC). Clin Chim Acta 1971;35:91-8.
11. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Tietz NW, ed. Textbook of clinical chemistry. Philadelphia, PA: WB Saunders, 1986:1578-82.
12. Auerbach M, Witt D, Toler W, Fierstein M, Lerner RG, Ballard H. Clinical use of the total dose intravenous infusion of iron dextran. J Lab Clin Med 1988;111:566-70.